Product NDC: | 0378-6203 |
Proprietary Name: | Verapamil Hydrochloride |
Non Proprietary Name: | verapamil hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; verapamil hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-6203 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078306 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130312 |
Package NDC: | 0378-6203-93 |
Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0378-6203-93) |
NDC Code | 0378-6203-93 |
Proprietary Name | Verapamil Hydrochloride |
Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0378-6203-93) |
Product NDC | 0378-6203 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | verapamil hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130312 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |